Aetiopathogenesis of autoimmune hepatitis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Autoimmunity

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jaut.2009.08.010PMID 19766456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis.

  2009cited by this paper
• Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T‐cells

  2009cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• The Human SepSecS-tRNASec Complex Reveals the Mechanism of Selenocysteine Formation

  2009cited by this paper
• Prevalence of hepatitis C serum antibody in autoimmune diseases.

  2009cited by this paper
• Mechanisms of foxp3+ T regulatory cell-mediated suppression.

  2009cited by this paper
• Human T regulatory cell therapy: take a billion or so and call me in the morning.

  2009cited by this paper
• End-Organ Damage in a Mouse Model of Fulminant Liver Inflammation Requires CD4+ T Cell Production of IFN-γ but Is Independent of Fas1

  2009cited by this paper
• AIRE Gene Analysis in Children With Autoimmune Hepatitis Type I or II

  2009cited by this paper
• Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage.

  2008cited by this paper
• Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

  2008cited by this paper
• Hepatitis resulting from liver-specific expression and recognition of self-antigen.

  2008cited by this paper
• Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis

  2008cited by this paper
• A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1

  2007cited by this paper
• Cytochrome P450IID6‐specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2

  2007cited by this paper
• Functional Study of CD4+CD25+ Regulatory T Cells in Health and Autoimmune Hepatitis1

  2006cited by this paper
• Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.

  2006cited by this paper
• Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseases.

  2005cited by this paper
• Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.

  2005cited by this paper
• Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis.

  2005cited by this paper
• A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens

  2004cited by this paper
• Genetic insights into disease mechanisms of autoimmunity.

  2004cited by this paper
• Genetics of autoimmune and viral liver diseases; understanding the issues.

  2004cited by this paper
• Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

  2004cited by this paper
• Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.

  2004cited by this paper
• Cytochrome P4502D6193–212: A New Immunodominant Epitope and Target of Virus/Self Cross-Reactivity in Liver Kidney Microsomal Autoantibody Type 1-Positive Liver Disease 1

  2003cited by this paper
• Cytotoxic T lymphocyte antigen–4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil

  2003cited by this paper
• The peripheral generation of CD4+ CD25+ regulatory T cells

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Genetics in Autoimmune Hepatitis

  2002cited by this paper
• Key Residues of a Major Cytochrome P4502D6 Epitope Are Located on the Surface of the Molecule1

  2002cited by this paper
• Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

  2002cited by this paper
• Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.

  2001cited by this paper
• Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity.

  2001cited by this paper
• Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

  2000cited by this paper
• Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane

  2000cited by this paper
• Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.

  2000cited by this paper
• Cytotoxic T lymphocyte antigen‐4 (CTLA‐4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

  2000cited by this paper
• Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort

  1999cited by this paper
• Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis.

  1999cited by this paper
• Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis.

  1999cited by this paper
• Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection

  1998cited by this paper
• MIMICRY BETWEEN HEPATITIS B VIRUS DNA POLYMERASE AND ANTIGENIC TARGETS OF NUCLEAR AND SMOOTH MUSCLE ANTIBODIES IN CHRONIC HEPATITIS B VIRUS INFECTION

  1997cited by this paper
• Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease.

  1997cited by this paper
• Non-organ specific autoantibodies in children with chronic hepatitis C.

  1996cited by this paper
• Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus.

  1994cited by this paper
• Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis.

  1992cited by this paper
• Liver‐infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro

  1992cited by this paper
• Class I and class II major histocompatibility complex antigens on hepatocytes: importance of the method of detection and expression in histologically normal and diseased livers.

  1991cited by this paper
• Clonal analysis of liver‐infiltrating T cells in patients with LKM‐1 antibody‐positive autoimmune chronic active hepatitis

  1991cited by this paper
• LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

  1991cited by this paper
• T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis.

  1990cited by this paper
• Class I and class II major histocompatibility complex antigen expression on hepatocytes: A study in children with liver disease

  1990cited by this paper
• Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily

  1988cited by this paper
• Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen.

  1987cited by this paper
• Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders.

  1986cited by this paper
• Antigen specific suppressor cell function in autoimmune chronic active hepatitis.

  1984cited by this paper
• Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis.

  1982cited by this paper
• Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.

  1979cited by this paper
• Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

  1978cited by this paper
• Letter: Adrenal suppression by clobetasol propionate.

  1975cited by this paper

• Ginsenoside, a potential natural product against liver diseases: a comprehensive review from molecular mechanisms to application

  2025cites this paper
• Galectins and Liver Diseases

  2025cites this paper
• Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis

  2025cites this paper
• The safety and efficacy of rituximab in autoimmune hepatitis: a systematic review and quality assessment.

  2025cites this paper
• The dual role of TIGIT in regulatory and effector T cells in chronic liver disease

  2025cites this paper
• Construction of the Single‐Cell Landscape of Hashimoto's Thyroiditis Tissue and Peripheral Blood by Single‐Cell RNA Sequencing

  2025cites this paper
• Characterization of CD24+ T Cells and Their Cytokine Signature in Autoimmune Hepatitis.

  2025cites this paper
• HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives.

  2025cites this paper
• Causal effects of plasma metabolites on autoimmune hepatitis (AIH): a bidirectional two-sample mendelian randomization study

  2024cites this paper
• Astaxanthin Alleviates Autoimmune Hepatitis by Modulating CD8+ T Cells: Insights From Mass Cytometry and Single‐Cell RNA Sequencing Analyses

  2024cites this paper
• Pleiotropic Action of TGF-Beta in Physiological and Pathological Liver Conditions

  2024cites this paper
• Macrophage polarization: an important role in inflammatory diseases

  2024cites this paper
• "Autoimmune Hepatitis: Insights into Classification, Pathogenesis, Diagnosis, and Therapeutic Strategies"

  2024cites this paper
• Curdlan-Decorated Fullerenes Mitigate Immune-Mediated Hepatic Injury for Autoimmune Hepatitis Therapeutics via Reducing Macrophage Infiltration

  2024cites this paper
• Complex interplay between the immune system, metabolism, and epigenetic factors in autoimmune liver diseases

  2023cites this paper
• Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis

  2023cites this paper
• Application on Mesenchymal Stem Cells in the Treatment of Chronic Liver Disease

  2023cites this paper
• Increased SLAMF7+CD8+ T cells are associated with the pathogenesis of experimental autoimmune pancreatitis in mice.

  2023cites this paper
• FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis

  2023cites this paper
• sFgl2 gene-modified MSCs regulate the differentiation of CD4+ T cells in the treatment of autoimmune hepatitis

  2023cites this paper
• L-lysine supplementation attenuates experimental autoimmune hepatitis in a chronic murine model

  2023cites this paper
• Effect of LncRNA XIST on Immune Cells of Primary Biliary Cholangitis

  2022cites this paper
• Exploring the Effective Components and Mechanism of Action of Japanese Ardisia in the Treatment of Autoimmune Hepatitis Based on Network Pharmacology and Experimental Verification

  2022cites this paper
• Advancing Biologic Therapy for Refractory Autoimmune Hepatitis

  2022cites this paper
• Moscatilin suppresses the inflammation from macrophages and T cells

  2022cites this paper
• RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism

  2022cites this paper
• The 2021 Incentive Award of the Okayama Medical Association in General Medical Science (2021 Yuuki Prize)

  2022cites this paper
• The immunological characteristics of TSPAN1 expressing B cells in autoimmune hepatitis

  2022cites this paper
• Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability.

  2021cites this paper
• Spred2 controls the severity of Concanavalin A-induced liver damage by limiting interferon-gamma production by CD4+ and CD8+ T cells

  2021influential citation
• IL-37 overexpression enhances therapeutic effect of endometrial regenerative cells in concanavalin A-induced hepatitis.

  2021cites this paper
• RIP3 Blockade Drives Myeloid-Derived Suppressor Cell-Mediated Immune Tolerance in Immune-Mediated Hepatitis

  2021cites this paper
• Classic Autoimmune Liver Disorders and Celiac Hepatitis

  2021cites this paper
• Formononetin protects against concanavalin-A-induced autoimmune hepatitis in mice through its anti-apoptotic and anti-inflammatory properties.

  2021cites this paper
• Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

  2021cites this paper
• Targeting Enclysis in Liver Autoimmunity, Transplantation, Viral Infection and Cancer

  2021cites this paper
• The relationship between myeloid-derived supressor cells and clinico-laboratory parameters in patients with liver cyrrosis

  2021cites this paper
• CQMUH‐011 mitigates autoimmune hepatitis via inhibiting the function of T lymphocytes

  2021cites this paper
• Autoimmmune hepatitis

  2021cites this paper
• Autoimmune liver diseases, hepatocellular carcinoma, and recurrence of autoimmunity post-liver transplantation

  2021cites this paper
• Synthesis and biological evaluation of novel schisanhenol derivatives as potential hepatoprotective agents.

  2021cites this paper
• Signal transducer and activator of transcription gene polymorphism in type 1autoimmune hepatitis

  2021cites this paper
• Autoimmune Liver Disease In Children

  2021cites this paper
• Blind liver biopsy: a 17-year experience Biopsia hepática a ciegas: experiencia de 17 años

  2021cites this paper
• Rapamycin alleviates experimental autoimmune hepatitis by immunoregulation of Th1 and Th17 cells

  2020cites this paper
• Blind liver biopsy: a 17-year experience.

  2020cites this paper
• Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis

  2020cites this paper
• The Pathogenesis of Liver Diseases in Pregnancy

  2020cites this paper
• Immune-Mediated Liver Disease in the Transplanted Liver

  2020cites this paper
• Hepatocytes paradoxically affect intrahepatic IFN-γ production in autoimmune hepatitis due to Gal-9 expression and TLR2/4 ligand release.

  2020cites this paper
• Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases

  2020cites this paper
• Characterization and functional prediction of the microRNAs differentially expressed in a mouse model of concanavalin A-induced autoimmune hepatitis

  2020cites this paper
• Adiponectin is Increased in Pediatric Patients With Autoimmune Hepatitis Independent of Body Weight

  2020cites this paper
• TIM‐3: An emerging target in the liver diseases

  2020cites this paper
• Circular RNAs associated with a mouse model of concanavalin A‐induced autoimmune hepatitis: preliminary screening and comprehensive functional analysis

  2020cites this paper
• Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis

  2020cites this paper
• Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis

  2020influential citation
• Mechanisms of autoimmune hepatitis

  2020cites this paper
• Seroprevalence of AIH-related autoantibodies in patients with acute hepatitis E viral infection: a prospective case–control study in China

  2020cites this paper
• Hepatitis

  2020cites this paper
• Autoimmune Hepatitis

  2020cites this paper
• The Effect of Human Embryonic Hepatocytes on Biochemical Indices at Acute Hepatic Failure in the Experiment

  2019cites this paper
• Galectin-9 in autoimmune hepatitis

  2019cites this paper
• The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study

  2019cites this paper
• Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response

  2019cites this paper
• Hypothyroidism and Hashimoto’s Thyroiditis: Mechanisms, Diagnosis, Neuropsychological Phenotypes, and Treatments

  2019cites this paper
• Autoimmune Hepatitis (AIH) in Acquired Immune Deficiency Syndrome (AIDS): A Case Report and Review of Literature

  2019cites this paper
• Attenuation of Experimental Autoimmune Hepatitis in Mice with Bone Mesenchymal Stem Cell-Derived Exosomes Carrying MicroRNA-223-3p

  2019cites this paper
• Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines

  2019cites this paper
• Exactitud de los criterios simplificados para el diagnóstico de la hepatitis autoinmune en población pediátrica. Una nueva propuesta basada en la clasificación espghan/napsghan 2009

  2019cites this paper
• A proliferation inducing ligand (APRIL), une molécule, deux fonctions opposées dans l'autoimmunité

  2019cites this paper
• IL‐37 suppresses the sustained hepatic IFN‐&ggr;/TNF‐&agr; production and T cell‐dependent liver injury

  2019cites this paper
• Autoimmune hepatitis type II in child

  2019cites this paper
• Autoimmune Hepatitis is more severe in Asian Australians

  2018cites this paper
• Effects of Cytokine-Induced killer cells on concanavalin-a induced hepatitis in mouse

  2018cites this paper
• Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management

  2018cites this paper
• Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome.

  2018cites this paper
• Noninvasive indices for monitoring disease course in Chinese patients with autoimmune hepatitis.

  2018cites this paper
• Review of Autoimmune Hepatitis: Diagnosis and Treatment

  2018cites this paper
• Autoimmune liver disease serology in acute hepatitis E virus infection.

  2018cites this paper
• Protective effects of Punica granatum (pomegranate) peel extract on concanavalin A-induced autoimmune hepatitis in mice.

  2018cites this paper
• TLR2/4 ligand‐amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL‐6/IL‐12/IL‐4/IL‐25 expression

  2018cites this paper
• Comparison of Concanavalin a-Induced Murine Autoimmune Hepatitis Models

  2018cites this paper
• Fumarate hydratase-specific T cell response in Chinese patients with autoimmune hepatitis.

  2018cites this paper
• Anti-CD200 attenuates concanavalin A induced hepatitis via modulating the imbalance of CD4+ T lymphocyte differentiation in mice.

  2018cites this paper
• Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis

  2018cites this paper
• Autoimmune Hepatitis After Liver Transplantation

  2017cites this paper
• Salvage Therapies for Autoimmune Hepatitis: A Critical Review

  2017cites this paper
• Sodium butyrate ameliorates S100/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor 4 signaling pathway.

  2017cites this paper
• LibGuides: Art: Open Access Introduction

  2017cites this paper
• The role of mesenchyme-mediated immune control theory in autoimmunity

  2017cites this paper
• Intrahepatic recruitment of cytotoxic NK cells contributes to autoimmune hepatitis progression.

  2017cites this paper
• Association of STAT4 and PTPN22 polymorphisms and their interactions with type-1 autoimmune hepatitis susceptibility in Chinese Han children

  2017cites this paper
• Influence of TBX21 T-1993C variant on autoimmune hepatitis development by Yin-Yang 1 binding

  2017cites this paper
• Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review

  2017cites this paper
• rs10499194 polymorphism in the tumor necrosis factor-α inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population

  2017cites this paper
• Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba

  2017cites this paper
• The Effects of Berberine on Concanavalin A-Induced Autoimmune Hepatitis (AIH) in Mice and the Adenosine 5′-Monophosphate (AMP)-Activated Protein Kinase (AMPK) Pathway

  2017cites this paper
• Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments

  2017cites this paper
• AUTOIMMUNE HEPATITIS AND PREGNANCY

  2017cites this paper